Chester County News and Community Website
Are you looking for Chester County businesses that are traded on the Nasdaq Stock Market? Would you love adding a Chester County business to your investment portfolio or 401k? The process of building a properly diversified portfolio, which includes investments in local businesses, is an important personal financial strategy.
Here you will find news and updates from Chester County businesses that are listed on the Nasdaq Stock Market. There is a growing appetite for real, local business news about publicly traded companies. MyChesCo features local business news from around Chester County. Moreover, we provide in-depth articles about Chester County’s dynamic business and economic scene, including tips for small biz owners, marketing, management, startups, entrepreneurship, and more.
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced Ted White, Verrica President & Chief Executive Officer, will present at the upcoming Jefferies Global Healthcare Conference, which is being …
Verrica Pharmaceuticals Announces Presentation at the Jefferies Global Healthcare Conference in London Read More
MALVERN, PA — Biopharmaceutical company Ocugen, Inc. (NASDAQ: OCGN) has announced the commencement of its Phase 1/2 GARDian clinical trial for OCU410ST (AAV5-hRORA), a gene therapy candidate being developed to …
Ocugen Initiates Phase 1/2 GARDian Clinical Trial for Stargardt Disease Therapy Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a leading player in the biotechnology industry, recently reported its financial results for the third quarter of 2023, marking an impressive 11th …
TELA Bio Reports Q3 2023 Results: 11th Consecutive Quarter of 35% YoY Growth Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), the makers of NeuroStar Advanced Therapy, recently announced vital healthcare policy updates from Magellan, BlueCross BlueShield (BCBS) of Kansas City, and Dean Health …
Neuronetics Gets Healthcare Policy Boost: Increased Patient Access to NeuroStar Therapy Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA recently announced financial results for the third quarter ended September 30, 2023.
Verrica Pharmaceuticals Reports Third Quarter 2023 Financial Results Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a frontrunner in the world of biopharmaceuticals, recently disclosed its Q3 2023 financial results and a business update that holds promising news for …
Ocugen’s Promising Advancements: Q3 2023 Financial Results and Progress in Ophthalmic Gene Therapies, Regenerative Cell Therapies, and Vaccines Portfolio Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has announced that its Chief Scientific Officer, Dr. Arun Upadhyay, will be a featured speaker at the prestigious 4th Annual Dry AMD Therapeutic …
Ocugen’s Chief Scientific Officer to Speak at the 4th Annual Dry AMD Therapeutic Development Summit Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a pioneer in the treatment of psychiatric disorders, announced its financial and operating results for the third quarter of 2023 this week. The …
Neuronetics Reports 8% Revenue Growth in Q3 2023, Expects Continued Momentum Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) this week announced the granting of inducement awards of Restricted Stock Units representing a total of 18,000 shares of the Company’s common stock …
Neuronetics Grants Restricted Stock Units as Inducement Awards Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) this week announced its financial results for the third quarter of 2023 and provided a corporate update.
Aclaris Therapeutics Reports Third Quarter 2023 Financial Results, Provides a Corporate Update Read More